Zhongjing Capital

Dolphin Intelligence focuses on large-model multimodal and edge computing technologies. Dolphin Intelligence specializes in AI-enhanced ultrasound equipment designed for primary medical applications. Their solutions aim to improve diagnostic efficiency and accessibility in healthcare.

Yichao Medical Technology is a medical equipment manufacturer.It provides E-ultrasound equipments.

Verity venture focuses on the active organization model, invests in an entrepreneurial way

Great Bay Bio Ltd. is a biotechnology company based in Central, Hong Kong, founded in 2002. It specializes in drug discovery and development by leveraging artificial intelligence technology within its Chemistry, Manufacturing, and Control (CMC) platform. The company focuses on the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. Great Bay Bio aims to create innovative biopharmaceuticals through a digital platform that integrates big data and Internet of Things technology. By harnessing high-quality resources from regions including Europe, the United States, Singapore, and Hong Kong, the company seeks to enhance the efficiency of drug development, significantly shortening development cycles and reducing costs, thus providing competitive advantages in the biotechnology industry.

Xiang He Capital is a venture capital firm founded in 2010 by Hesong Tang and Maggie Yang, with headquarters in Palo Alto and operations in Beijing. The firm specializes in early and growth-stage investments within the technology, media, and telecommunications (TMT) sector in China. With a team that boasts extensive experience in corporate development from Baidu and other leading internet companies, Xiang He Capital leverages strategic analysis and strong industry connections to identify promising investment opportunities. The firm targets a range of areas, including artificial intelligence, online education, logistics, fintech, online medical systems, and various internet-based services. Through its investment strategy, Xiang He Capital aims to drive innovation and facilitate the transformation of traditional industries.

Alwin Capital is a Beijing-based venture capital firm established in 2015, specializing in early-stage investments within the life science sector. The firm emphasizes theme-focused research to identify and capitalize on opportunities in innovative diagnostics and therapeutics. With a commitment to long-term investments driven by scientific insights, Alwin Capital aims to generate exceptional returns. Founded by former senior executives from CICC, the firm leverages decades of experience in healthcare research and medical markets. Currently, Alwin Capital manages three venture funds with over RMB 1 billion in assets under management and has invested in numerous life science companies, fostering the development of leading firms in various segments of the industry.

Founded in 2011, Joy Capital is a venture capital firm primarily focused on the technology and innovative consumption sectors. With over a decade of experience investing in startups across Europe, North America, and Asia, they have invested in over 80 companies, with many achieving unicorn status.

Gaolin Capital Management Co., Ltd. is a principal investment firm based in Beijing, China, founded in 2014. The company specializes in equity investments across various sectors, including healthcare and wellness, biotechnology, gene testing, medical equipment, and healthcare management. Additionally, Gaolin Capital explores opportunities in consumer services, social network entertainment, internet finance, education, as well as new materials and technologies. The firm is committed to providing comprehensive investment and financing services, aiming to support innovative enterprises in its targeted industries.

China Everbright Water Limited is a prominent provider of water environmental management services, primarily operating in Mainland China and Germany. The company specializes in a wide range of services, including municipal and industrial waste water treatment, water supply, sludge treatment, and the development of reusable water solutions. It is also involved in sponge city construction, river-basin ecological restoration, and leachate treatment. Additionally, China Everbright Water engages in project investment, planning, design, and operations management, alongside conducting research and development in water environment technologies. The firm operates numerous water treatment projects, boasting a designed daily waste water treatment capacity exceeding 6 million cubic meters. With a strong presence across various regions in China, including major provinces and autonomous areas, the company plays a critical role in addressing the country's water management challenges while adhering to long-term concession arrangements with government authorities. Based in Shenzhen, China Everbright Water Limited is a subsidiary of China Everbright Water Holdings Limited.

QF Capital is a fund management company that specializes in private equity and venture capital investments. It primarily targets early-stage small and medium enterprises, emphasizing sectors such as the internet of things, modern services, and new materials. By focusing on these innovative areas, QF Capital aims to support the growth and development of promising companies, driving advancements in technology and services.